Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Pharmaceutical and Device
Pharmaceutical Pricing – A Reminder of the Value Equation
We previously wrote about the actions Congress is taking to "combat rising prescription drug prices," and the rhetoric…
The Politics of Drug Pricing
The 2016 presidential race is fraught with hot-button issues, with each party and each candidate taking positions on…
Hillary Clinton Unveils New Plan for Lowering Drug Cost
Yesterday, Democratic Presidential candidate Hillary Clinton proposed a new plan to address pharmaceutical “price…
Debunking Myths About ‘Big Pharma’
We recently wrote about the media’s coverage of the 2013 Open Payments data, noting the ease in which a government database…
Supreme Court Passes on Challenge to Alameda’s Drug Disposal…
The Supreme Court has declined to hear a challenge to Alameda County’s Drug Disposal Ordinance. The Court’s decision…
A Tough Road: Cost To Develop One New Drug Is $2.6 Billion; Approval Rate…
Developing a new prescription medicine that gains marketing approval is estimated to cost drugmakers $2.6 billion according to a…
False Claims Act: Device Maker Settles For $8 Million For Allegedly Selling…
An interesting False Claims Act issue cropped up in a recent $8 million settlement involving U.K.-based medical device…
PhRMA Innovation Hub Highlights Research and Advances in the…
The Pharmaceutical Research and Manufacturers of America (PhRMA) recently launched an impressive website—the “Innovation…
DEA Places Heavy Restrictions on Vicodin and Other Hydrocodone Combination…
On Friday, August 22, the U. S. Drug Enforcement Administration (DEA) published their Final Rule moving hydrocodone…
Pharmaceutical Adherence Programs Vital to Lowering Health Costs
New survey research from Ernst & Young (EY) finds that the majority of payers in the US and Europe believe that drug…